GB1337068A - Muscle-relaxant compositions - Google Patents

Muscle-relaxant compositions

Info

Publication number
GB1337068A
GB1337068A GB3133471A GB3133471A GB1337068A GB 1337068 A GB1337068 A GB 1337068A GB 3133471 A GB3133471 A GB 3133471A GB 3133471 A GB3133471 A GB 3133471A GB 1337068 A GB1337068 A GB 1337068A
Authority
GB
United Kingdom
Prior art keywords
muscle
july
acid addition
addition salt
skeletal muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3133471A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Charles E Frosst and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charles E Frosst and Co filed Critical Charles E Frosst and Co
Publication of GB1337068A publication Critical patent/GB1337068A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

1337068 Skeletal muscle relaxants CHARLES E FROSST & CO 5 July 1971 [7 July 1970] 31334/71 Heading ASB Pharmaceutical dosage units having skeletal muscle relaxant activity comprise (a) 1-25 mg of cyclobenzaprine or an acid addition salt thereof and (b) a carrier. The acid addition salt may be the hydrochloride. The dosage unit may be a tablet for oral administration or an injectable solution in sterile water.
GB3133471A 1970-07-07 1971-07-05 Muscle-relaxant compositions Expired GB1337068A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA87562 1970-07-07

Publications (1)

Publication Number Publication Date
GB1337068A true GB1337068A (en) 1973-11-14

Family

ID=4087146

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3133471A Expired GB1337068A (en) 1970-07-07 1971-07-05 Muscle-relaxant compositions

Country Status (15)

Country Link
BE (1) BE769517A (en)
CA (1) CA958643A (en)
CY (1) CY885A (en)
FR (1) FR2100873B1 (en)
GB (1) GB1337068A (en)
HK (1) HK4077A (en)
IE (1) IE35419B1 (en)
IL (1) IL37173A (en)
KE (1) KE2690A (en)
MT (1) MTP698B (en)
MY (1) MY7700127A (en)
NL (1) NL7108745A (en)
PH (1) PH12038A (en)
ZA (1) ZA713719B (en)
ZM (1) ZM9571A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110558A1 (en) * 2011-04-06 2012-10-07 Campiglio Consulting Srl PHARMACEUTICAL COMPOSITION CONTAINING CYCLOBENZAPRINE SUITABLE FOR ENDONASAL ADMINISTRATION

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508280A (en) * 1990-05-18 1996-04-16 Merrell Pharmaceuticals, Inc. 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
ES2109268T3 (en) * 1990-05-18 1998-01-16 Merrell Pharma Inc 5H-DIBENZO (A, D) CYCLLOHEPTENES USED AS MUSCARINIC RECEPTOR ANTAGONISTS.
BR0013017A (en) 1999-08-13 2002-04-16 Vela Pharmaceuticals Inc Uses of compositions for the treatment or prevention of sleep disorders using very low doses of cyclobenzaprine
CA2380373A1 (en) 1999-08-13 2001-02-22 Seth Lederman Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454643A (en) * 1959-04-27 1969-07-08 Arthur C Cope 5 - (tertiaryaminoalkylene)-5 hydroxy- and 5-(tertiary aminoalkylidene) - dibenzocycloheptatrienes,and salts thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110558A1 (en) * 2011-04-06 2012-10-07 Campiglio Consulting Srl PHARMACEUTICAL COMPOSITION CONTAINING CYCLOBENZAPRINE SUITABLE FOR ENDONASAL ADMINISTRATION
WO2012137054A1 (en) * 2011-04-06 2012-10-11 Campiglio Consulting Srl Pharmaceutical composition containing cyclobenzaprine suitable to intranasal administration

Also Published As

Publication number Publication date
FR2100873A1 (en) 1972-03-24
HK4077A (en) 1977-01-28
MY7700127A (en) 1977-12-31
CY885A (en) 1977-03-18
IE35419L (en) 1972-01-07
KE2690A (en) 1977-01-28
NL7108745A (en) 1972-01-11
BE769517A (en) 1972-01-05
MTP698B (en) 1971-11-03
ZM9571A1 (en) 1973-04-24
FR2100873B1 (en) 1974-08-02
IL37173A0 (en) 1971-08-25
IE35419B1 (en) 1976-02-04
PH12038A (en) 1978-10-16
CA958643A (en) 1974-12-03
ZA713719B (en) 1973-01-31
IL37173A (en) 1975-02-10

Similar Documents

Publication Publication Date Title
EP0137542A3 (en) Pharmaceutical composition for the treatment of states of acute renal insufficiency
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
GB1380171A (en) Medicinal tablets
GB1337068A (en) Muscle-relaxant compositions
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
GB1202148A (en) Pharmaceutical compositions
GB1442159A (en) Pharmaceutical compositions containing paracetamol
IL37139A0 (en) Triakoxybenzoyl aminoalkanoic acid derivatives and pharmaceutical compositions containing them
GB1118606A (en) Compositions for the treatment of haemorrhoids
GB1327464A (en) Pharmaceutical composition for inhibiting indoleamine-n- methyl transferase
GB950162A (en) Medicines for the treatment of hepatic disorders
GB1352392A (en) Phenylisopropylamine derivatives
GB1339636A (en) Pharmaceutical compositions for inducing skeletal muscle relaxation
GB1375806A (en)
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GB1454390A (en) Nasal decongestants
BE768813A (en) SUBSTITUTE AMINOALKANOIC ACIDS, THEIR ACCEPTABLE SALTS FOR PHARMACEUTICAL USE, THEIR PREPARATION AND THEIR THERAPEUTIC USES
GB1287433A (en) Pharmaceutical compositions
GB1334326A (en) Skeletal muscle relaxant compositions
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
GB1250279A (en)
ES385521A1 (en) Azamorphinan compounds
GB911179A (en) Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years